We are live on ! Find out more
TRVI icon

Trevi Therapeutics
TRVI

18 hedge funds and large institutions have $17.4M invested in Trevi Therapeutics in 2021 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

6% more funds holding

Funds holding: 17 → 18 (+1)

4.98% less ownership

Funds ownership: 62.61% → 57.63% (-5%)

38% less capital invested

Capital invested by funds: $28.1M → $17.4M (-$10.7M)

Holders
18
Holders Change
+1
Holders Change %
+5.88%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
4
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$32.1K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$5.9K
3
UBS Group
UBS Group
Switzerland
+$5.38K
4
TRCT
Tower Research Capital (TRC)
New York
+$1.09K
5
HI
Harbour Investments
Wisconsin
+$443

Top Sellers

Rank Fund Capital Flow
1
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
-$56K
2
Renaissance Technologies
Renaissance Technologies
New York
-$48K
3
WA
WealthTrust Axiom
Pennsylvania
-$5.31K
4
BlackRock
BlackRock
New York
-$498
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$8.32M – – –
TGHSA
2
TPG Group Holdings (SBS) Advisors
Texas
$6.75M – – –
OFM
3
Omega Fund Management
Massachusetts
$1.77M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$192K +$5.9K +3,334 +3%
Renaissance Technologies
5
Renaissance Technologies
New York
$92K -$48K -27,100 -29%
Geode Capital Management
6
Geode Capital Management
Massachusetts
$67K – – –
BlackRock
7
BlackRock
New York
$61K -$498 -281 -0.6%
WA
8
WealthTrust Axiom
Pennsylvania
$51K -$5.31K -3,000 -8%
BCM
9
Bridgeway Capital Management
Texas
$47K – – –
Citadel Advisors
10
Citadel Advisors
Florida
$25K +$32.1K +18,147 New
Northern Trust
11
Northern Trust
Illinois
$16K – – –
LPL Financial
12
LPL Financial
California
$14K – – –
TRCT
13
Tower Research Capital (TRC)
New York
$7K +$1.09K +616 +15%
UBS Group
14
UBS Group
Switzerland
$7K +$5.38K +3,036 +142%
First Manhattan
15
First Manhattan
New York
$4K – – –
AIMCA
16
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
– -$56K -25,000 Closed
Wells Fargo
17
Wells Fargo
California
– +$23 +13 +39%
HI
18
Harbour Investments
Wisconsin
– +$443 +250 New

TRVI Hedge Fund Activity: Q3 2021 in Review

18 of the 5,713 institutional investors tracked by Wall St. Rank reported a position in Trevi Therapeutics (TRVI) for Q3 2021, worth a combined $17.4M — down 38% from $28.1M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TRVI positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $32.1K. The largest seller was Alberta Investment Management Corp (AIMCo), exiting entirely with an estimated $56K sold.

  • 18 institutional investors held Trevi Therapeutics (TRVI) as of Q3 2021, up from 17 in Q2 2021.
  • Funds reported $17.4M of Trevi Therapeutics stock for Q3 2021, down 38% quarter-over-quarter.
  • 2 funds opened new Trevi Therapeutics positions in Q3 2021 and 1 closed out, a net change of +1 holder.
  • The largest Trevi Therapeutics buyer in Q3 2021 was Citadel Advisors, an estimated $32.1K added.
  • The largest Trevi Therapeutics seller in Q3 2021 was Alberta Investment Management Corp (AIMCo), an estimated $56K sold.

Based on aggregated 13F filings for Q3 2021.